logo
Aetna Drops Out of ACA Exchange In 2026—Here's How It Could Affect You

Aetna Drops Out of ACA Exchange In 2026—Here's How It Could Affect You

Forbes6 days ago
Editorial Note: We earn a commission from partner links on Forbes Advisor. Commissions do not affect our editors' opinions or evaluations.
CVS Health, owner of Aetna, announced that Aetna will withdraw all Affordable Care Act (ACA) individual and family plans at the end of 2025. Coverage will continue through December 31, 2025, but starting January 1, 2026, Aetna-branded ACA plans will no longer be available.
Aetna cited persistent underperformance in the ACA exchange business, including substantial financial losses. CVS reserved about $448 million to cover anticipated losses in 2025, and leadership concluded there was no viable path to profitability in this market.
Roughly one million ACA enrollees across 17 states will need to find new coverage for 2026. The most impacted states include: Arizona
California
Delaware
Florida
Georgia
Illinois
Indiana
Kansas
Maryland
Missouri
Nevada
New Jersey
North Carolina
Ohio
Texas
Utah
Virginia
If you have an Aetna ACA plan right now, no need to worry—your coverage will stick around through the end of 2025. But when fall rolls around, it's smart to start exploring new options.
During Open Enrollment , expected to run from November 1, 2025, through mid-January 2026, you'll need to switch to a new insurer for 2026. This shift may be straightforward for some, but others may have to change doctors or hospitals if they aren't part of your new plan's network.
To help with this transition, you can expect outreach from health insurance brokers or messaging from the federal government. While Aetna covers just 4% of national ACA enrollees, its exit could have ripple effects in certain areas.
This isn't Aetna's first time pulling back from the ACA marketplace. After exiting in 2018 and coming back in 2022, the company is shifting gears once again.
Its parent company, CVS Health, is zeroing in on more profitable areas, such as pharmacy services and popular weight-loss drugs like Wegovy. That focus appears to be working: CVS reported nearly a 60% jump in first-quarter profits, pushing its stock price to new highs. Keep an eye out. Sometime around mid-2025, you'll get a letter or email saying it's time to pick a new plan. When open enrollment starts on November 1, 2025, visit HealthCare.gov or your state site to review your options and check if you qualify for discounts. If you're feeling overwhelmed, you can always ask an agent or broker to help navigate you through the process. Remember to make sure your usual doctors and hospitals are in-network, or you might have to switch providers.
Aetna's exit is prompting a recalibration of the ACA marketplace. Smaller, ACA-focused insurers such as Centene, which offers plans under the Ambetter brand, and Oscar Health prepare to absorb many of Aetna's displaced members.
At the same time, uncertainty around federal policy remains a concern. The enhanced subsidies that have kept premiums affordable are set to expire unless renewed. Without them, many enrollees could face higher costs, and insurers may become more selective in the risks they're willing to take on.
If you're losing your Aetna ACA plan, don't stress, as plenty of other options are available. Some of the best insurance companies , like Ambetter, Oscar Health and Molina Healthcare, are stepping up to cover folks in many states.
You might also qualify for Medicaid or the Children's Health Insurance Program (CHIP) , especially if your income has changed or you have kids. These programs usually don't cost much and can serve as a solid backup.
Short-term health plans are available, too, but they don't cover everything and usually exclude any preexisting health issues. Of course, it's always worth checking if you or someone in your family can get coverage through work. When Open Enrollment kicks off, take your time to review your options and choose the plan that best fits your needs.
Aetna will exit the ACA exchanges entirely after 2025, impacting around one million members across 17 states. Existing coverage remains through the end of 2025, and if the changes impact you, plan to shop for a new ACA plan during Open Enrollment in late 2025.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Here is Why ProPetro Holding (PUMP) Plunged This Week
Here is Why ProPetro Holding (PUMP) Plunged This Week

Yahoo

time13 minutes ago

  • Yahoo

Here is Why ProPetro Holding (PUMP) Plunged This Week

The share price of ProPetro Holding Corp. (NYSE:PUMP) fell by 13.3% between July 11 and July 18, 2025, putting it among the Energy Stocks that Lost the Most This Week. An oil derrick silhouetted against a rising sun with a blue sky in the background. ProPetro Holding Corp. (NYSE:PUMP) is an oilfield services company that engages in the provision of hydraulic fracturing and other complementary services. ProPetro Holding Corp. (NYSE:PUMP) plunged this week following a downturn witnessed in the overall oilfield services sector, amid reports of a slowdown in drilling activity and a broader pullback in exploration and production spending. Analysts expect the sector to post a decline in earnings in the Q2 earnings season, as well as a drop in guidance for the second half of the year. Moreover, investors may also have reacted to ProPetro Holding Corp. (NYSE:PUMP) recently announcing a change in leadership, with Mr. Caleb Weatherl appointed as the company's new CFO on July 14, 2025. Following the recent decline, the share price of ProPetro Holding Corp. (NYSE:PUMP) has plunged by over 42% since the beginning of 2025. While we acknowledge the potential of PUMP as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 12 Best Oil and Gas Dividend Stocks to Buy Now and The 5 Energy Stocks Billionaires are Quietly Piling Into. Disclosure: None. Sign in to access your portfolio

Target downgraded, Dollar Tree upgraded: Wall Street's top analyst calls
Target downgraded, Dollar Tree upgraded: Wall Street's top analyst calls

Yahoo

time13 minutes ago

  • Yahoo

Target downgraded, Dollar Tree upgraded: Wall Street's top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The 5 Upgrades: Barclays upgraded Dollar Tree (DLTR) to Overweight from Equal Weight with a price target of $120, up from $95. The company is positioned to benefit from a trade down by consumes, which will accelerates in the second half of 2025, the firm tells investors in a research note. Morgan Stanley upgraded Pinterest (PINS) to Overweight from Equal Weight with a price target of $45, up from $37. The firm's advertising checks are constructive on Pinterest's improving ad efficiency and performance-driven growth. Morgan Stanley upgraded Etsy (ETSY) to Equal Weight from Underweight with a price target of $50, up from $38. The firm sees a more balanced catalyst path for the shares after they underperformed the S&P 500 Index by 20% over the past year. Seaport Research upgraded both Analog Devices (ADI) and Texas Instruments (TXN) to Neutral from Sell with no price target. While the firm sees "no strong catalysts," it acknowledges that it was "wrong" in its prior thought that the analog inventory cycle was not going to improve and the macro economy was slowing. Monness Crespi upgraded Fiserv (FI) to Neutral from Sell with no price target, telling investors that the firm sees fair value at about $155 per share. The firm's sense is that the market has been looking to revalue the stock as long as the Clover volume trajectory remains above double digits over the medium term and it recommends investors to "be ready" for the next opportunity. Top 5 Downgrades: Barclays downgraded Target (TGT) to Underweight from Equal Weight with an unchanged price target of $91. The firm says that absent a bigger strategic shift, the company's sales will continue to underperform. Needham downgraded Sarepta (SRPT) to Underperform from Hold without a price target. The company late Friday reported receiving an informal request from the FDA to voluntarily halt shipments of Elevidys and that it denied this request, the firm tells investors in a research note. Mizuho, Leerink, and Baird also downgraded Sarepta to Neutral-equivalent ratings, while Deutsche Bank cut its rating on the name to Sell. Truist downgraded Biogen (BIIB) to Hold from Buy with a price target of $142, down from $199, after a transfer in coverage. The stock's discounted multiple versus pees is warranted given the "suboptimal" growth outlook for Biogen's commercial franchise, the firm tells investors in a research note. Argus downgraded Elevance Health (ELV) to Hold from Buy, citing the ongoing pressures on the company's profit margins from medical cost trends in its Medicaid and ACA marketplace businesses. Truist downgraded Royal Caribbean (RCL) to Hold from Buy with a price target of $337, up from $275. Truist has observed a bounce-back in bookings since April's pullback, but when averaging March-early July's year over year bookings, demand pace is only up low-to-mid-single digits, well off the high-teens monthly pace that 2024 averaged, the firm tells investors in a research note. Top 5 Initiations: Loop Capital initiated coverage of Autodesk (ADSK) with a Hold rating and $320 price target. Loop is constructive on Autodesk's long-term prospects but believes the stock's current valuation reflects much of its expected growth and execution improvements. Benchmark initiated coverage of General Motors (GM) with a Buy rating and $65 price target, calling the stock "a compelling opportunity for investors seeking exposure to a durable, cash-generative U.S. industrial franchise with underappreciated upside potential." Oppenheimer initiated coverage of Affirm (AFRM) with an Outperform rating and $80 price target, offering 15% upside potential. The firm argues that Affirm stands out as a leader in the Buy Now, Pay Later space with its advanced underwriting, robust funding strategy, strong merchant relationships, and transparent pricing model. Stephens initiated coverage of Paylocity (PCTY) with an Equal Weight rating and $200 price target. The firm believes the company is well positioned to gain share "while navigating sub-optimal labor market conditions," but believes the valuation reflects expectations of a conservative guide with modest outperformance. Barclays initiated coverage of Kroger (KR) with an Equal Weight rating and $75 price target. The firm is positive on Kroger's post-deal refocus. Barclays also started Sprouts Farmers (SFM) with an Equal Weight and Albertsons (ACI) with an Underweight. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Core Laboratories (CLB) Falls Amid a Difficult Time for the Oilfield Services Sector
Core Laboratories (CLB) Falls Amid a Difficult Time for the Oilfield Services Sector

Yahoo

time13 minutes ago

  • Yahoo

Core Laboratories (CLB) Falls Amid a Difficult Time for the Oilfield Services Sector

The share price of Core Laboratories Inc. (NYSE:CLB) fell by 11.35% between July 11 and July 18, 2025, putting it among the Energy Stocks that Lost the Most This Week. A drilling rig manned by engineers and oil field workers preparing to explore a new petroleum reservoir. Core Laboratories Inc. (NYSE:CLB) is a leading global provider of proprietary and patented reservoir description and production enhancement services and products for the oil and gas industry. Core Laboratories Inc. (NYSE:CLB) slumped this week after Stifel lowered the firm's price target from $13 to $12, while maintaining a 'Hold' rating on its shares. The move reflects the analyst's overall bearish outlook for the overall oilfield services sector, which has significantly underperformed the broader market since the beginning of 2025. The oil and gas services industry is expected to post a decline in profits this earnings season due to an overall slowdown in drilling activity, caused by falling crude oil prices and global economic uncertainty due to President Trump's tariff war. It is also expected that the guidance for the second half of this year will probably be lowered among oilfield contractors, further weighing down their stocks. While we acknowledge the potential of CLB as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 12 Best Oil and Gas Dividend Stocks to Buy Now and The 5 Energy Stocks Billionaires are Quietly Piling Into. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store